Trial Profile

A clinical trial of MRx0518 in combination with stereotactic body radiotherapy (SBRT) for the treatment of pancreatic cancer

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 10 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs CJRB 102 (Primary)
Indications Pancreatic cancer
Focus Adverse reactions

Most Recent Events

05 Jan 2020 Status changed from planning to recruiting, according to a 4D Pharma PLC media release.
05 Jan 2020 According to a 4D Pharma PLC, Cullen M. Taniguchi, M.D., Ph.D., Assistant Professor of Radiation Oncology at MD Anderson, is the principal investigator for the study.
05 Nov 2019 According to a 4D Pharma PLC, this trial is expected to start before year end 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com